ArticleJournal of translational medicine2026
Reinforcement learning-based WSI diagnostic system for cervical squamous cell carcinoma and precancerous lesions.
Article in Journal of translational medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe prevention of cervical cancer relies on the accurate histopathological grading of its precursor lesions, particularly Squamous Intraepithelial Lesions (SIL), which can progress to Squamous Cell Carcinoma (SCC) if left undiagnosed or misclassified. However, the diagnostic evaluation of these lesions is often hindered by subjective interpretation, resulting in significant inter-observer variability. This inconsistency directly affects clinical decisions and emphasizes the urgent need for an objective, standardized diagnostic tool
methodsTo address this issue, we developed an AI framework that mimics the diagnostic workflow of expert pathologists by integrating two core innovations. First, a domain-specific feature extractor, CerviScan-ViT, captures subtle patterns in the tissue architecture critical for distinguishing SIL from normal tissue and identifying high-risk lesions. Second, a reinforcement learning agent, SmartPatchRL, intelligently navigates whole slide images (WSIs) to perform a policy-driven search for diagnostically critical regions, enhancing both efficiency and focus.
resultsValidated in a multi-center, prospective and retrospective setting, our framework sets a new performance benchmark, achieving 90.6% accuracy during the testing phase and demonstrating robust generalization to external data. Notably, the model's interpretable heatmaps highlight its ability to focus on true lesion-defining features while effectively disregarding slide preparation artifacts that often lead to over-grading in traditional models.
conclusionThis work offers a highly accurate, generalizable, and trustworthy solution poised to standardize SIL and SCC grading and improve the reliability of cervical cancer screening, ultimately aiding in early detection and prevention of both SIL and SCC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.